Brief: CytoDyn Announces Partial Clinical Hold Of HIV Program And Full Clinical Hold Of Covid-19 Program
30/03/2022 22:04
March 30 (Reuters) - CytoDyn Inc CYDY.PK :
* CYTODYN ANNOUNCES PARTIAL CLINICAL HOLD OF HIV PROGRAM AND
FULL
CLINICAL HOLD OF COVID-19 PROGRAM
* CYTODYN INC - U.S. FDA HAS PLACED A PARTIAL CLINICAL HOLD
ON ITS
HIV PROGRAM AND A FULL CLINICAL HOLD ON ITS COVID-19 PROGRAM IN
UNITED STATES
Source text for Eikon: ID:nGNX459rC6
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer